Authors: PHILLIPS P DEBEULE K FRECHETTE G TCHAMOUROFF S VANDERCAM B WEITNER L HOEPELMAN A STINGL G CLOTET B

Citation: P. Phillips et al., A DOUBLE-BLIND COMPARISON OF ITRACONAZOLE ORAL SOLUTION AND FLUCONAZOLE CAPSULES FOR THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PATIENTSWITH AIDS, Clinical infectious diseases, 26(6), 1998, pp. 1368-1373

Authors: DEREPENTIGNY L RATELLE J LECLERC JM CORNU G SOKAL EM JACQMIN P DEBEULE K

Citation: L. Derepentigny et al., REPEATED-DOSE PHARMACOKINETICS OF AN ORAL SOLUTION OF ITRACONAZOLE ININFANTS AND CHILDREN, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 404-408

Authors: VANDEWOUDE K VOGELAERS D DECRUYENAERE J JAQMIN P DEBEULE K VANPEER A WOESTENBORGHS R GROEN K COLARDYN F

Citation: K. Vandewoude et al., CONCENTRATIONS IN PLASMA AND SAFETY OF 7 DAYS OF INTRAVENOUS ITRACONAZOLE FOLLOWED BY 2 WEEKS OF ORAL ITRACONAZOLE SOLUTION IN PATIENTS IN INTENSIVE-CARE UNITS, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2714-2718

Authors: DEBEULE K

Citation: K. Debeule, ITRACONAZOLE - PHARMACOLOGY, CLINICAL-EXPERIENCE AND FUTURE-DEVELOPMENT, International journal of antimicrobial agents, 6(3), 1996, pp. 175-181

Authors: VANDENENDEN E VANGOMPEL A STEVENS A VANDEGHINSTE N LERAY D GIGASE P DEBEULE K VANDENENDE J

Citation: E. Vandenenden et al., TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ORAL ITRACONAZOLE, International journal of dermatology, 33(4), 1994, pp. 285-286